EnteroMedics, Inc.
2800 Patton Road
St Paul,
MN 55113
United States - Map
Phone: 651-634-3003
Web Site: http://www.enteromedics.com
| EnteroMedics Inc., a development stage medical device company, focuses on design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders. Its proprietary neuroblocking technology is designed to intermittently block the vagus nerve using electrical impulses. The companys initial product under development is the Maestro System, which is used to limit the expansion of the stomach, control hunger sensations between meals, reduce the frequency and intensity of stomach contractions, and produce a feeling of early and prolonged fullness. It focuses on marketing its product to potential referral source clinicians, such as general practitioners, internists, endocrinologists, and nurses. EnteroMedics has collaboration with Mayo Clinic for research and development of devices for vagal blocking therapy to treat obesity. The company formerly known as Beta Medical, Inc. and changed its name to EnteroMedics, Inc. in October 2003. EnteroMedics was founded in 2002 and is headquartered in St. Paul, Minnesota. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Mark B. Knudson Ph.D., 58
Chief Exec. Officer and Pres |
$
490.00K |
$
0 | Dr. Katherine S. Tweden Ph.D.,
Co-Founder and VP of Research & Clinical |
$
282.00K |
$
0 | Mr. Gregory S. Lea , 56
Chief Financial Officer, Principal Accounting Officer, Sr. VP and Sec. |
$
340.00K |
$
0 | Mr. Adrianus Donders , 56
Sr. VP of Operations |
$
346.00K |
$
0 | Mr. Nicholas L. Teti Jr., 56
Special Advisor to Chief Exec. Officer |
$
20.00K | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
0.02 (4.17%) 
Profile
